title: Her-2 targeting in uterine papillary serous carcinoma.
abstract: ► A case of metastatic uterine papillary serous cancer with Her-2 gene amplification. ► Was treated with a Her-2 targeted agent and achieved durable remission. ► Her-2 targeting should be considered alone or in combination with chemotherapy.
authors.affiliation: Department of Hematology/Oncology, St. Luke's Roosevelt Hospital Center, New York, NY, USA.
authors.forename: Sumit
authors.initials: S
authors.lastname: Talwar
authors.affiliation: Department of Hematology/Oncology, St. Luke's Roosevelt Hospital Center, New York, NY, USA.
authors.forename: Seth
authors.initials: S
authors.lastname: Cohen
keywords: Endometrial cancer; Her-2; Papillary serous carcinoma; Targeted therapy